VYOME HOLDINGS, INC. Payments to Acquire Short-term Investments
VYOME HOLDINGS, INC. (HIND) reported Payments to Acquire Short-term Investments of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2020-02-27
- VYOME HOLDINGS, INC. payments to acquire short-term investments for the quarter ending 2019-12-31 was $0.00.
- VYOME HOLDINGS, INC. payments to acquire short-term investments for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. payments to acquire short-term investments for the quarter ending 2018-12-31 was -$1.00K, a 100.01% decline year-over-year.
- VYOME HOLDINGS, INC. payments to acquire short-term investments for the quarter ending 2018-09-30 was $8.11M, a 47.31% decline year-over-year.
- VYOME HOLDINGS, INC. payments to acquire short-term investments for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- VYOME HOLDINGS, INC. payments to acquire short-term investments for fiscal 2018 was $9.10M, a 90.38% decline from fiscal 2017.
- VYOME HOLDINGS, INC. payments to acquire short-term investments for fiscal 2017 was $94.61M, a 400.68% increase from fiscal 2016.
- VYOME HOLDINGS, INC. payments to acquire short-term investments for fiscal 2016 was $18.90M, a 1.65% increase from fiscal 2015.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 10-K · filed 2020-02-27 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 10-Q · filed 2019-11-08 | ||
| 2019-06-30 | $0.00 10-Q · filed 2019-07-24 | |||
| 2018-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $8.11M derived: sum of 2 quarters · filed 2020-02-27 | $9.10M derived: sum of 3 quarters · filed 2020-02-27 | $9.10M 10-K · filed 2020-02-27 |
| 2018-09-30 | $8.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $9.10M derived: sum of 2 quarters · filed 2019-11-08 | $9.10M 10-Q · filed 2019-11-08 | $23.40M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $995.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $995.00K 10-Q · filed 2019-07-24 | $15.29M derived: sum of 3 quarters · filed 2019-07-24 | $30.68M derived: sum of 4 quarters · filed 2019-07-24 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | $14.30M derived: sum of 2 quarters · filed 2019-02-22 | $29.68M derived: sum of 3 quarters · filed 2019-02-22 | $69.58M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-12-31 | $14.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $29.68M derived: sum of 2 quarters · filed 2019-02-22 | $69.58M derived: sum of 3 quarters · filed 2019-02-22 | $94.61M 10-K · filed 2019-02-22 |
| 2017-09-30 | $15.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $55.29M derived: sum of 2 quarters · filed 2018-11-02 | $80.32M 10-Q · filed 2018-11-02 | $80.32M derived: sum of 4 quarters · filed 2018-11-02 |
| 2017-06-30 | $39.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $64.93M 10-Q · filed 2018-08-02 | $64.93M derived: sum of 3 quarters · filed 2018-08-02 | $68.85M derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-03-31 | $25.03M 10-Q · filed 2018-05-10 | $25.03M derived: sum of 2 quarters · filed 2018-05-10 | $28.95M derived: sum of 3 quarters · filed 2018-05-10 | $41.92M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $3.92M derived: sum of 2 quarters · filed 2018-03-05 | $16.89M derived: sum of 3 quarters · filed 2018-03-05 | $18.90M 10-K · filed 2018-03-05 |
| 2016-09-30 | $3.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $16.89M derived: sum of 2 quarters · filed 2017-11-03 | $18.90M 10-Q · filed 2017-11-03 | $23.25M derived: sum of 4 quarters · filed 2018-03-05 |
| 2016-06-30 | $12.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $14.98M 10-Q · filed 2017-08-02 | $19.33M derived: sum of 3 quarters · filed 2018-03-05 | |
| 2016-03-31 | $2.01M 10-Q · filed 2017-05-10 | $6.36M derived: sum of 2 quarters · filed 2018-03-05 | ||
| 2015-12-31 | $4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $18.59M 10-K · filed 2018-03-05 | ||
| 2015-09-30 | $14.24M 10-Q · filed 2016-11-10 | |||
| 2014-12-31 | $12.40M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |